Oneness Biotech

4743 · TPEx

Public Market Listing

4743TPEx

TPEx primary exchange listing

Live quotes, historical charts, and market capitalization for Oneness Biotech are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Phase 2
CεmX domain of membrane-bound IgE (mIgE)Monoclonal antibody
Atopic Dermatitis

Upcoming events

(2 total)

Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (2)
May 2027 (1)
FB825Phase 2Atopic Dermatitis
Est. primary completion 2027-05-31 · NCT06397911 · CT.gov ↗
What to watch
December 2027 (1)
FB825Phase 2Allergic Asthma
Est. primary completion 2027-12 · NCT05008965 · CT.gov ↗
What to watch

See the full readout calendar ↗

Financial reports

Quarterly & interim (1)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2026-Q1$1.2M——$4.8Mreport ↗